Biolab is one of the largest pharmaceutical companies in Brazil. They develop, manufacture, and market a wide portfolio of medicines, with a strong focus on cardiovascular and dermatological products. Their R&D efforts include innovation in drug formulations and exploring new delivery mechanisms to improve therapeutic outcomes.
Sao Paulo
1997
1,001–5,000
